Back
ALX Oncology Holdings Vs. Verve Therapeutics Industry Stock Comparison
Buy
54
ALXO
ALX Oncology Holdings
Last Price:
1.41
Seasonality Move:
3.52%
Sell
25
VERV
Verve Therapeutics
Last Price:
4.85
Seasonality Move:
-11.16%
Buy
54
ALX Oncology Holdings (ALXO)
is a Buy
Is ALX Oncology Holdings a Buy, Sell or Hold?
- The current ALX Oncology Holdings [ALXO] share price is $1.41. The Score for ALXO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ALXO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $4.85. The Score for VERV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALXO Stock Price Chart
What is ALX Oncology Holdings's stock price today?
-
The ALX Oncology Holdings share price today is $1.41
The current trend is relatively stagnant and ALXO is experiencing buying pressure, which is a positive indicator for future bullish movement.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $4.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALXO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 47.34 | Sell |
| Chaikin Money Flow: | 625655 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.3 - 1.52) | Sell |
| Bollinger Bands (100): | (0.93 - 4.73) | Sell |
VERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 40.26 | Sell |
| Chaikin Money Flow: | 1039980 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.04 - 6.28) | Sell |
| Bollinger Bands (100): | (4.83 - 6.53) | Sell |
ALXO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.29 | Buy |
| 20-day SMA: | 1.39 | Buy |
| 50-day SMA: | 1.62 | Sell |
| 200-day SMA: | 7.78 | Sell |
| 8-day EMA: | 1.32 | Buy |
| 20-day EMA: | 1.39 | Buy |
| 50-day EMA: | 1.84 | Sell |
| 200-day EMA: | 5.68 | Sell |
VERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.91 | Sell |
| 20-day SMA: | 5.65 | Sell |
| 50-day SMA: | 5.36 | Sell |
| 200-day SMA: | 7.32 | Sell |
| 8-day EMA: | 4.99 | Sell |
| 20-day EMA: | 5.35 | Sell |
| 50-day EMA: | 5.47 | Sell |
| 200-day EMA: | 7.4 | Sell |
ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and a decrease next year of $0.58 per share.
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.
ALX Oncology Holdings Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verve Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||